Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity
β-Glucan is a polysaccharide that can be extracted from fungal cell walls. Wellmune WGP ® , a preparation of β-1,3/1,6-glucans, is a dietary supplement that has immunomodulating properties. Here we investigated the effect WGP had on a mouse model of asthma. OVA-induced asthma in mice is characterize...
Gespeichert in:
| Veröffentlicht in: | SpringerPlus 2016-06, Vol.5 (1), p.815-815, Article 815 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 815 |
|---|---|
| container_issue | 1 |
| container_start_page | 815 |
| container_title | SpringerPlus |
| container_volume | 5 |
| creator | Burg, Ashley R. Quigley, Laura Jones, Adam V. O’Connor, Geraldine M. Boelte, Kimberly McVicar, Daniel W. Orr, Selinda J. |
| description | β-Glucan is a polysaccharide that can be extracted from fungal cell walls. Wellmune WGP
®
, a preparation of β-1,3/1,6-glucans, is a dietary supplement that has immunomodulating properties. Here we investigated the effect WGP had on a mouse model of asthma. OVA-induced asthma in mice is characterized by infiltration of eosinophils into the lung, production of Th2 cytokines and IgE. Daily oral administration of WGP (400 µg) significantly reduced the influx of eosinophils into the lungs of OVA-challenged mice compared to control mice. In addition, WGP inhibited pulmonary production of Th2 cytokines (IL-4, IL-5, IL-13), however serum IgE levels were unaffected by WGP treatment. These data indicate that WGP could potentially be useful as an oral supplement for some asthma patients, however, it would need to be combined with therapies that target other aspects of the disease such as IgE levels. As such, further studies that examine the potential of WGP in combination with other therapies should be explored. |
| doi_str_mv | 10.1186/s40064-016-2501-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4916077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1802738740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-2915ea426010f950822a7700d878ede6bec640d7919ace51036b8884807134d43</originalsourceid><addsrcrecordid>eNp9kcFuFSEUhonR2Kb2AdwYlm5Gz2EYYDYmplFr0qSbuibcmXPvpZmBKzA181o-iM8kzW2bupENJP9_fuD_GHuL8AHRqI9ZAijZAKpGdIANvmCnAvu2QQP48tn5hJ3nfAt1KY1Sw2t2InTbg-q6U2avk5umlbtx9sHnQolG_ud3s5uWwQXuSqGwuEKZlz3xm73gifIhhkzcV5nPcaSJxy13Pv1yK9-vB0qZQvbF3_myvmGvtm7KdP6wn7EfX7_cXFw2V9ffvl98vmoG2UNpRI8dOSkUIGz7DowQTmuA0WhDI6kNDUrCqHvs3UAdQqs2xhhpQGMrR9mesU_H3MOymWkcKJT6MXtIfnZptdF5-68S_N7u4p2VPSrQuga8fwhI8edCudjZ54GmyQWKS7a1ydqa0RKqFY_WIcWcE22frkGw92zskY2tbOw9G4t15t3z9z1NPJKoBnE05CqFHSV7G5cUamf_Sf0LDF6bCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1802738740</pqid></control><display><type>article</type><title>Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Burg, Ashley R. ; Quigley, Laura ; Jones, Adam V. ; O’Connor, Geraldine M. ; Boelte, Kimberly ; McVicar, Daniel W. ; Orr, Selinda J.</creator><creatorcontrib>Burg, Ashley R. ; Quigley, Laura ; Jones, Adam V. ; O’Connor, Geraldine M. ; Boelte, Kimberly ; McVicar, Daniel W. ; Orr, Selinda J.</creatorcontrib><description>β-Glucan is a polysaccharide that can be extracted from fungal cell walls. Wellmune WGP
®
, a preparation of β-1,3/1,6-glucans, is a dietary supplement that has immunomodulating properties. Here we investigated the effect WGP had on a mouse model of asthma. OVA-induced asthma in mice is characterized by infiltration of eosinophils into the lung, production of Th2 cytokines and IgE. Daily oral administration of WGP (400 µg) significantly reduced the influx of eosinophils into the lungs of OVA-challenged mice compared to control mice. In addition, WGP inhibited pulmonary production of Th2 cytokines (IL-4, IL-5, IL-13), however serum IgE levels were unaffected by WGP treatment. These data indicate that WGP could potentially be useful as an oral supplement for some asthma patients, however, it would need to be combined with therapies that target other aspects of the disease such as IgE levels. As such, further studies that examine the potential of WGP in combination with other therapies should be explored.</description><identifier>ISSN: 2193-1801</identifier><identifier>EISSN: 2193-1801</identifier><identifier>DOI: 10.1186/s40064-016-2501-1</identifier><identifier>PMID: 27390655</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Biomedical and Life Sciences ; Humanities and Social Sciences ; multidisciplinary ; Science ; Science (multidisciplinary)</subject><ispartof>SpringerPlus, 2016-06, Vol.5 (1), p.815-815, Article 815</ispartof><rights>The Author(s) 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-2915ea426010f950822a7700d878ede6bec640d7919ace51036b8884807134d43</citedby><cites>FETCH-LOGICAL-c490t-2915ea426010f950822a7700d878ede6bec640d7919ace51036b8884807134d43</cites><orcidid>0000-0001-8539-7825</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916077/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916077/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27390655$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burg, Ashley R.</creatorcontrib><creatorcontrib>Quigley, Laura</creatorcontrib><creatorcontrib>Jones, Adam V.</creatorcontrib><creatorcontrib>O’Connor, Geraldine M.</creatorcontrib><creatorcontrib>Boelte, Kimberly</creatorcontrib><creatorcontrib>McVicar, Daniel W.</creatorcontrib><creatorcontrib>Orr, Selinda J.</creatorcontrib><title>Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity</title><title>SpringerPlus</title><addtitle>SpringerPlus</addtitle><addtitle>Springerplus</addtitle><description>β-Glucan is a polysaccharide that can be extracted from fungal cell walls. Wellmune WGP
®
, a preparation of β-1,3/1,6-glucans, is a dietary supplement that has immunomodulating properties. Here we investigated the effect WGP had on a mouse model of asthma. OVA-induced asthma in mice is characterized by infiltration of eosinophils into the lung, production of Th2 cytokines and IgE. Daily oral administration of WGP (400 µg) significantly reduced the influx of eosinophils into the lungs of OVA-challenged mice compared to control mice. In addition, WGP inhibited pulmonary production of Th2 cytokines (IL-4, IL-5, IL-13), however serum IgE levels were unaffected by WGP treatment. These data indicate that WGP could potentially be useful as an oral supplement for some asthma patients, however, it would need to be combined with therapies that target other aspects of the disease such as IgE levels. As such, further studies that examine the potential of WGP in combination with other therapies should be explored.</description><subject>Biomedical and Life Sciences</subject><subject>Humanities and Social Sciences</subject><subject>multidisciplinary</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><issn>2193-1801</issn><issn>2193-1801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kcFuFSEUhonR2Kb2AdwYlm5Gz2EYYDYmplFr0qSbuibcmXPvpZmBKzA181o-iM8kzW2bupENJP9_fuD_GHuL8AHRqI9ZAijZAKpGdIANvmCnAvu2QQP48tn5hJ3nfAt1KY1Sw2t2InTbg-q6U2avk5umlbtx9sHnQolG_ud3s5uWwQXuSqGwuEKZlz3xm73gifIhhkzcV5nPcaSJxy13Pv1yK9-vB0qZQvbF3_myvmGvtm7KdP6wn7EfX7_cXFw2V9ffvl98vmoG2UNpRI8dOSkUIGz7DowQTmuA0WhDI6kNDUrCqHvs3UAdQqs2xhhpQGMrR9mesU_H3MOymWkcKJT6MXtIfnZptdF5-68S_N7u4p2VPSrQuga8fwhI8edCudjZ54GmyQWKS7a1ydqa0RKqFY_WIcWcE22frkGw92zskY2tbOw9G4t15t3z9z1NPJKoBnE05CqFHSV7G5cUamf_Sf0LDF6bCg</recordid><startdate>20160621</startdate><enddate>20160621</enddate><creator>Burg, Ashley R.</creator><creator>Quigley, Laura</creator><creator>Jones, Adam V.</creator><creator>O’Connor, Geraldine M.</creator><creator>Boelte, Kimberly</creator><creator>McVicar, Daniel W.</creator><creator>Orr, Selinda J.</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8539-7825</orcidid></search><sort><creationdate>20160621</creationdate><title>Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity</title><author>Burg, Ashley R. ; Quigley, Laura ; Jones, Adam V. ; O’Connor, Geraldine M. ; Boelte, Kimberly ; McVicar, Daniel W. ; Orr, Selinda J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-2915ea426010f950822a7700d878ede6bec640d7919ace51036b8884807134d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biomedical and Life Sciences</topic><topic>Humanities and Social Sciences</topic><topic>multidisciplinary</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burg, Ashley R.</creatorcontrib><creatorcontrib>Quigley, Laura</creatorcontrib><creatorcontrib>Jones, Adam V.</creatorcontrib><creatorcontrib>O’Connor, Geraldine M.</creatorcontrib><creatorcontrib>Boelte, Kimberly</creatorcontrib><creatorcontrib>McVicar, Daniel W.</creatorcontrib><creatorcontrib>Orr, Selinda J.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>SpringerPlus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burg, Ashley R.</au><au>Quigley, Laura</au><au>Jones, Adam V.</au><au>O’Connor, Geraldine M.</au><au>Boelte, Kimberly</au><au>McVicar, Daniel W.</au><au>Orr, Selinda J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity</atitle><jtitle>SpringerPlus</jtitle><stitle>SpringerPlus</stitle><addtitle>Springerplus</addtitle><date>2016-06-21</date><risdate>2016</risdate><volume>5</volume><issue>1</issue><spage>815</spage><epage>815</epage><pages>815-815</pages><artnum>815</artnum><issn>2193-1801</issn><eissn>2193-1801</eissn><abstract>β-Glucan is a polysaccharide that can be extracted from fungal cell walls. Wellmune WGP
®
, a preparation of β-1,3/1,6-glucans, is a dietary supplement that has immunomodulating properties. Here we investigated the effect WGP had on a mouse model of asthma. OVA-induced asthma in mice is characterized by infiltration of eosinophils into the lung, production of Th2 cytokines and IgE. Daily oral administration of WGP (400 µg) significantly reduced the influx of eosinophils into the lungs of OVA-challenged mice compared to control mice. In addition, WGP inhibited pulmonary production of Th2 cytokines (IL-4, IL-5, IL-13), however serum IgE levels were unaffected by WGP treatment. These data indicate that WGP could potentially be useful as an oral supplement for some asthma patients, however, it would need to be combined with therapies that target other aspects of the disease such as IgE levels. As such, further studies that examine the potential of WGP in combination with other therapies should be explored.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>27390655</pmid><doi>10.1186/s40064-016-2501-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-8539-7825</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2193-1801 |
| ispartof | SpringerPlus, 2016-06, Vol.5 (1), p.815-815, Article 815 |
| issn | 2193-1801 2193-1801 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4916077 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Biomedical and Life Sciences Humanities and Social Sciences multidisciplinary Science Science (multidisciplinary) |
| title | Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A29%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Orally%20administered%20%CE%B2-glucan%20attenuates%20the%20Th2%20response%20in%20a%20model%20of%20airway%20hypersensitivity&rft.jtitle=SpringerPlus&rft.au=Burg,%20Ashley%20R.&rft.date=2016-06-21&rft.volume=5&rft.issue=1&rft.spage=815&rft.epage=815&rft.pages=815-815&rft.artnum=815&rft.issn=2193-1801&rft.eissn=2193-1801&rft_id=info:doi/10.1186/s40064-016-2501-1&rft_dat=%3Cproquest_pubme%3E1802738740%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1802738740&rft_id=info:pmid/27390655&rfr_iscdi=true |